We are live on
!
Find out more
GT
Greenleaf Trust Portfolio holdings
AUM
$10.2B
1-Year Est. Return
2.09%
This Fund
S&P 500
This Quarter
Est. Return
-4.47%
1 Year Est. Return
+2.09%
3 Year Est. Return
+37.36%
5 Year Est. Return
+56.79%
10 Year Est. Return
+256.01%
AUM
$10.2B
AUM Growth
-$732M
(-6.7%)
Cap. Flow
-$192M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
73.86%
Holding
862
New
46
Increased
425
Reduced
285
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$74.5M |
| 2 |
Janus Henderson AAA CLO ETF
JAAA
|
+$20.3M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$18.3M |
| 4 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$14M |
| 5 |
Copart
CPRT
|
+$7.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$225M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$51.5M |
| 3 |
Invesco Ultra Short Duration ETF
GSY
|
+$12.6M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$11.3M |
| 5 |
PayPal
PYPL
|
+$8.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.06% |
| 2 | Technology | 6.57% |
| 3 | Financials | 3.68% |
| 4 | Communication Services | 2.61% |
| 5 | Consumer Discretionary | 2.16% |
Similar funds
VPIM
ACA
IIM
GI
RA
OIA
BEI
RI
Greenleaf Trust's Q1 2026 Portfolio in Review
As of Q1 2026, Greenleaf Trust held 862 positions worth $10.2B, down 6.7% from $10.9B the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Greenleaf Trust's Q1 2026 filing shows 46 new, 425 increased, 285 reduced and 58 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 67,543 shares worth $7.46M. The largest sale was Stryker, an estimated $225M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 55% a quarter earlier, followed by Technology and Financials.
- Greenleaf Trust's largest Q1 2026 buy was iShares 0-1 Year Treasury Bond ETF: 67,543 shares worth $7.46M.
- Greenleaf Trust added most to State Street SPDR Portfolio S&P 500 ETF in Q1 2026, an estimated $74.5M increase.
- Greenleaf Trust's biggest Q1 2026 reduction was Stryker, cutting an estimated $225M.
- Greenleaf Trust fully exited AstraZeneca in Q1 2026, selling an estimated $2.37M.
- Greenleaf Trust's ten largest holdings make up 74% of its $10.2B portfolio in Q1 2026.
- Greenleaf Trust opened 46 new positions and closed 58 in Q1 2026.
- Greenleaf Trust's portfolio value fell 6.7% quarter-over-quarter to $10.2B.
Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.